Insider buying
~$7.2K727 sh @ $9.94
Traded Mar 19 · filed 11 days later
A major shareholder of AdaptHealth paid $7.2K out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 27, 2026 · Filed Mar 3, 2026
An AdaptHealth director paid $72K out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month. Shares held went up 8% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$71,680
Shares × reported transaction price
$25K–$100K
+8.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
3 days after results of Feb 24, 2026, 67 days before results of May 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $9.15 on Feb 27, 2026, 25% above its 52-week low and 20% below its high, after a 13% drop over the previous 30 trading days
52-week range $7.33 (Apr 21, 2025) to $11.38 (Feb 28, 2025), 45% of the way up, from 251 adjusted closes. 30 trading days earlier: $10.54 on Jan 14, 2026. Describes the past only, not a forecast
RSI 38, 3% under its 200-day average, 10% under its 50-day average, 20% below the 52-week high, 20-day volatility 66% a year, against the S&P 500: −4 points over 1 month, −7 points over 3 months, −7 points over 6 months
From the adjusted closes up to Feb 27, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Dale B Wolf's first purchase of AHCO since May 2021
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | −1.3% | +2.1% |
| 30 days | +24.8% | −3.8% | +28.6% |
| 90 days | −0.2% | +10.9% | −11.1% |
| 180 days | −42.2% | +12.0% | −54.1% |
Past results only. Not a forecast.
Insider buying
Traded Mar 19 · filed 11 days later
A major shareholder of AdaptHealth paid $7.2K out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month.
Insider buying
Traded Mar 11 · filed 19 days later
A major shareholder of AdaptHealth paid $5.22M out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month.
Insider buying
Largest insider buy since 2018Traded Mar 10 · filed 20 days later
A major shareholder of AdaptHealth paid $7.98M out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.